S&P Global Ratings affirms Bristol Myers Squibb at "A+" (Local Currency LT credit rating); outlook stable
May 2, 2022 Cbonds
Show full article |
This functionality is available for registred users only
|
Company — Bristol Myers Squibb

-
Full nameBristol-Myers Squibb Company
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
Share